Barton Gold Holdings Converts 43,686 Director Fee Options to Shares at $0.74, Increasing Total Shares to 270.5 Million

Barton Gold Seeks ASX Quotation for 43,686 Shares After Director Option Exercises

On 16 July 2026, Barton Gold Holdings Limited filed an Appendix 2A application with the ASX to quote 43,686 new ordinary fully paid shares. These shares resulted from the exercise of unquoted options held by key management personnel, converting two separate option classes into quoted ordinary shares. The issue date for these shares is 16 July 2026, and they rank equally with existing shares from that date.

The company confirmed that the exercised options came from two distinct series, originally issued to directors as an alternative to cash director fees. This arrangement allows the company to conserve cash while compensating directors, with the exercised options converting non-cash remuneration into equity. The total shares issued from both tranches amount to 43,686 ordinary shares now pending quotation.

Two BGD Option Series Exercised: BGDAG (July 2026) and BGDAP (October 2026)

The first tranche involves the BGDAG option series expiring 26 July 2026, exercisable at nil cost. A total of 18,536 options were exercised on 16 July 2026, converting into an equal number of fully paid shares. The estimated value per share was $0.74, based on the 15 July 2026 closing price.

The second tranche covers the BGDAP option series expiring 11 October 2026, also exercisable at nil cost. A total of 25,150 options were converted into fully paid shares on the same date, applying the same $0.74 estimated share value. These shares are intended for ASX quotation but were unquoted at the time of application. Combined, both tranches total 43,686 new shares seeking quotation.

Key Management Personnel Graham Arvidson and Christian Paech Exercise Options Across Both Series

Two key management personnel exercised options from both series. Graham Arvidson, via Hagosan Pty Ltd, converted 9,268 BGDAG options and 12,575 BGDAP options, totaling 21,843 shares. Christian Paech exercised the same number of options in each series, also totaling 21,843 shares. Their simultaneous exercises suggest coordinated management of remuneration entitlements ahead of the BGDAG series expiry in July 2026.

These options were not part of an employee incentive scheme but specifically tied to director fee arrangements, with disclosure obligations under ASX Listing Rules and the Corporations Act 2001.

Nil Exercise Price Reflects Director Fee-Based Option Grants

Both option series have a nil exercise price, meaning no cash was paid upon conversion. This aligns with their issuance as alternatives to cash director fees, where economic consideration was provided at grant rather than exercise. This approach helps smaller listed companies conserve cash while fulfilling director remuneration obligations and aligns directors’ interests with company performance through equity exposure.

While the nil-cost exercise is straightforward, investors should interpret these conversions within the broader operational context rather than as standalone bullish signals.

BGD’s Total Ordinary Shares Reach 270,519,004 After Quotation Application

With the addition of 43,686 shares, Barton Gold’s total quoted ordinary shares will rise to 270,519,004, as per the Appendix 2A filing. This figure is generated automatically by the ASX and may not reflect simultaneous changes from other filings. Investors should consider this when assessing dilution.

Although the share count increase is modest relative to total issued capital, such incremental issuances from director fee arrangements are common governance practices among ASX-listed companies. No guidance on further issuances was provided in this update.

Remaining Unquoted BGD Options After 16 July 2026 Exercise

The filing also notes 34,013 unquoted options remain under the BGDAH series, expiring 16 January 2027 with nil exercise price. These options are not traded on the ASX but could convert to ordinary shares if exercised before expiry, potentially requiring further quotation applications.

The company did not disclose holders or original terms of the BGDAH options beyond the filing’s summary.

$0.74 Reference Price Used to Value Exercised Options

Barton Gold applied a $0.74 per share estimated value for both option tranches, corresponding to the closing price on 15 July 2026. This reference price provides an estimated aggregate value for disclosure purposes but does not represent a cash transaction price since the options have a nil exercise price.

The immediate market impact of this exercise and quotation was not publicly clear. The reference price aids analysts in estimating the notional value of director remuneration and the market value of shares added through this transaction. No additional commentary or guidance was provided.

Investor Considerations Following Director Option Exercises

Investors should monitor the upcoming expiry of the BGDAH options on 16 January 2027, as their exercise could lead to further share issuances and ASX quotation applications. Tracking Barton Gold’s option register and future filings will clarify potential dilution from director fee-related options.

Moreover, Barton Gold’s use of nil-cost options in place of cash fees is a distinctive element of its remuneration framework, differentiating these issuances from capital raisings or equity placements. Investors assessing governance and director-shareholder alignment should consider how ongoing option conversions affect capital structure and director remuneration value. No operational or strategic updates accompanied this filing; for broader context, investors should review the company’s latest operational reports and project updates.